Pfizer
PFE
PFE
3,257 hedge funds and large institutions have $202B invested in Pfizer in 2022 Q4 according to their latest regulatory filings, with 342 funds opening new positions, 1,267 increasing their positions, 1,335 reducing their positions, and 101 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
6% more funds holding
Funds holding: 3,076 → 3,257 (+181)
0.5% more ownership
Funds ownership: 69.12% → 69.62% (+0.5%)
5% less repeat investments, than reductions
Existing positions increased: 1,267 | Existing positions reduced: 1,335
Holders
3,257
Holding in Top 10
193
Calls
$3.09B
Puts
$2.77B
Top Buyers
| 1 | +$492M | |
| 2 | +$462M | |
| 3 | +$386M | |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$381M |
| 5 |
Morgan Stanley
New York
|
+$356M |
Top Sellers
| 1 | -$553M | |
| 2 | -$442M | |
| 3 | -$418M | |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$187M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$181M |